Cargando…
Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma
Osteosarcoma (OS) is a common type of bone tumor for which there has been limited therapeutic progress over the past three decades. The prevalence of transcriptional addiction in cancer cells emphasizes the biological significance and clinical relevance of super-enhancers. In this study, we found th...
Autores principales: | Guo, Weitang, Wang, Xin, Lu, Bing, Yu, Jiaming, Xu, Mingxian, Huang, Renxuan, Cheng, Mingzhe, Yang, Meiling, Zhao, Wei, Zou, Changye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352384/ https://www.ncbi.nlm.nih.gov/pubmed/37460542 http://dx.doi.org/10.1038/s41419-023-05966-y |
Ejemplares similares
-
Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma
por: Huang, Renxuan, et al.
Publicado: (2023) -
Evolution of the Max and Mlx Networks in Animals
por: McFerrin, Lisa G., et al.
Publicado: (2011) -
Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes
por: Singh, Parmveer, et al.
Publicado: (2016) -
The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis
por: Carroll, Patrick A., et al.
Publicado: (2021) -
The glucose-sensing transcription factor MLX promotes myogenesis via myokine signaling
por: Hunt, Liam C., et al.
Publicado: (2015)